Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation

Science Translational Medicine

Volumn 4, Issue 124, 2012, Pages

  Leventhal, Joseph ^a   Abecassis, Michael ^a   Miller, Joshua ^a   Gallon, Lorenzo ^a   Ravindra, Kadiyala ^b   Tollerud, David J ^b,c   King, Bradley ^b,c   Elliott, Mary Jane ^b   Herzig, Geoffrey ^b   Herzig, Roger ^b   Ildstad, Suzanne T ^b,c  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c Regenerex LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD34 ANTIGEN; CD56 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUDARABINE; HLA ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADULT; ALPHABETA T LYMPHOCYTE; ARTICLE; B LYMPHOCYTE; BIOENGINEERING; CD19+ B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; ENGRAFTMENT SYNDROME; FACILITATING CELL; FEMALE; GENE LOCUS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOLOGICAL MONITORING; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LYMPHOCYTE SUBPOPULATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MONOTHERAPY; NEUTROPHIL COUNT; NONMYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL ARTERY THROMBOSIS; REPRODUCIBILITY; SAFETY; SEPSIS; STEM CELL MOBILIZATION; T LYMPHOCYTE; TREATMENT DURATION; UNRELATED DONORS; VIRAL SEPSIS; WHOLE BODY RADIATION; WOUND INFECTION; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED;

ADULT; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TACROLIMUS;

EID: 84863229939     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003509     Document Type: Article

References (40)

1. S. T. Ildstad, H. Shirwan, J. Leventhal, Is durable macrochimerism key to achieving clinical transplantation tolerance? Curr. Opin. Organ Transplant. 16, 343-344 (2011).
2. S. T. Ildstad, D. H. Sachs, Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307, 168-170 (1984).
3. C. A. Huang, Y. Fuchimoto, R. Scheier-Dolberg, M. C. Murphy, D. M. Neville Jr., D. H. Sachs, Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J. Clin. Invest. 105, 173-181 (2000).
4. J. D. Scandling, S. Busque, S. Dejbakhsh-Jones, C. Benike, M. T. Millan, J. A. Shizuru, R. T. Hoppe, R. Lowsky, E. G. Engleman, S. Strober, Tolerance and chimerism after renal and hematopoietic-cell transplantation. N. Engl. J. Med. 358, 362-368 (2008).
5. T. Kawai, A. B. Cosimi, T. R. Spitzer, N. Tolkoff-Rubin, M. Suthanthiran, S. L. Saidman, J. Shaffer, F. I. Preffer, R. Ding, V. Sharma, J. A. Fishman, B. Dey, D. S. Ko, M. Hertl, N. B. Goes, W. Wong, W. W. Williams Jr., R. B. Colvin, M. Sykes, D. H. Sachs, HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358, 353-361 (2008).
6. D. H. Sachs, M. Sykes, T. Kawai, A. B. Cosimi, Immuno-intervention for the induction of transplantation tolerance through mixed chimerism. Semin. Immunol. 23, 165-173 (2011).
7. M. T. Millan, J. A. Shizuru, P. Hoffmann, S. Dejbakhsh-Jones, J. D. Scandling, F. C. Grumet, J. C. Tan, O. Salvatierra, R. T. Hoppe, S. Strober, Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 73, 1386-1391 (2002).
8. C. L. Kaufman, Y. L. Colson, S. M. Wren, S. Watkins, R. L. Simmons, S. T. Ildstad, Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84, 2436-2446 (1994).
9. I. J. Fugier-Vivier, F. Rezzoug, Y. Huang, A. J. Graul-Layman, C. L. Schanie, H. Xu, P. M. Chilton, S. T. Ildstad, Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 201, 373-383 (2005).
10. H. L. Grimes, C. L. Schanie, Y. Huang, D. Cramer, F. Rezzoug, I. Fugier-Vivier, S. T. Ildstad, Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes. Exp. Hematol. 32, 946-954 (2004).
11. + regulatory T cells following hemopoietic stem cell transplantation: Role of bone marrow-derived facilitating cells. J. Immunol. 179, 2153-2162 (2007).
12. + plasmacytoid precursor DCs induce antigen-specific regulatory T cells that enhance HSC engraftment in vivo. Blood 117, 2494-2505 (2011).
13. Y. L. Colson, K. Christopher, J. Glickman, K. N. Taylor, R. Wright, D. L. Perkins, Absence of clinical GVHD and the in vivo induction of regulatory T cells after transplantation of facilitating cells. Blood 104, 3829-3835 (2004).
14. A. B. Farris, D. Taheri, T. Kawai, L. Fazlollahi, W. Wong, N. Tolkoff-Rubin, T. R. Spitzer, A. J. Iafrate, F. I. Preffer, S. A. LoCascio, B. Sprangers, S. Saidman, R. N. Smith, A. B. Cosimi,M. Sykes,D. H. Sachs, R. B. Colvin, Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am. J. Transplant. 11, 1464-1477 (2011).
15. A. O. Ojo, P. J. Held, F. K. Port, R.A. Wolfe, A. B. Leichtman, E. W. Young, J. Arndorfer, L. Christensen, R. M. Merion, Chronic renal failure after transplantation of a nonrenal organ. N. Engl. J. Med. 349, 931-940 (2003).
16. M. Sénéchal, R. Dorent, S. T. du Montcel, J. J. Ghossou, A. Pavie, T. Petitclerc, M. Dubois, R. Isnard, I. Gandjbakhch, End-stage renal failure and cardiac mortality after heart transplantation. Clin. Transplant. 18, 1-6 (2004).
17. C. Li, C. W. Yang, The pathogenesis and treatment of chronic allograft nephropathy. Nat. Rev. Nephrol. 5, 513-519 (2009).
18. M. S. Orloff, E. M. DeMara, M. L. Coppage, N. Leong, X. J. Zuo, J. Prehn, S. C. Jordan, Alterations of the interleukin-4 pathway in production of tolerance by mixed hematopoietic chimerism. Surgery 118, 212-219 (1995).
19. L. H. Bühler, T. R. Spitzer, M. Sykes, D. H. Sachs, F. L. Delmonico, N. Tolkoff-Rubin, S. L. Saidman, R. Sackstein, S. McAfee, B. Dey, C. Colby, A. B. Cosimi, Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 74, 1405-1409 (2002).
20. T. Kawai, A. B. Cosimi, D. H. Sachs, Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism. Curr. Opin. Organ Transplant. 16, 366-371 (2011).
21. T. Kawai, D. H. Sachs, T. Spitzer, N. Tolkoff-Rubin, R. B. Colvin, S. Saidman, D. S. C. Ko, W. Wong, W. Williams, M. Sykes, A. B. Cosimi, Tolerance of renal allografts across HLA barriers: Follow-up on the first trial and initial results of the second, paper presented at the XXIII International Congress of the Transplantation Society, Vancouver, Canada, 15 to 19 August 2010.
22. L. Luznik, P. V. O'Donnell, H. J. Symons, A. R. Chen, M. S. Leffell, M. Zahurak, T. A. Gooley, S. Piantadosi, M. Kaup, R. F. Ambinder, C. A. Huff, W. Matsui, J. Bolaños-Meade, I. Borrello, J. D. Powell, E. Harrington, S. Warnock, M. Flowers, R. A. Brodsky, B. M. Sandmaier, R. F. Storb, R. J. Jones, E. J. Fuchs, HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol. Blood Marrow Transplant. 14, 641-650 (2008).
23. Q. Mao, P. I. Terasaki, J. Cai, K. Briley, P. Catrou, C. Haisch, L. Rebellato, Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am. J. Transplant. 7, 864-871 (2007).
24. J. D. Scandling, S. Busque, J. A. Shizuru, E. G. Engleman, S. Strober, Induced immune tolerance for kidney transplantation. N. Engl. J. Med. 365, 1359-1360 (2011).
25. F. Rezzoug, Y. Huang, M. K. Tanner, M. Wysoczynski, C. L. Schanie, P. M. Chilton, M. Z. Ratajczak, I. J. Fugier-Vivier, S. T. Ildstad, TNF-α is critical to facilitate hemopoietic stem cell engraftment and function. J. Immunol. 180, 49-57 (2008).
26. + regulatory T cells by a bone marrow population distinct from plasmacytoid-DC. Cell. Immunol. 251, 43-49 (2008).
27. A. N. McMurchy, A. Bushell, M. K. Levings, K. J. Wood, Moving to tolerance: Clinical application of T regulatory cells. Semin. Immunol. 23, 304-313 (2011).
28. Y. L. Colson, S. M. Wren, M. J. Schuchert, D. K. Patrene, P. C. Johnson, S. S. Boggs, S. T. Ildstad, A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J. Immunol. 155, 4179-4188 (1995).
29. R. E. Gress, S. G. Emerson, W. R. Drobyski, Immune reconstitution: How it should work, what's broken, and why it matters. Biol. Blood Marrow Transplant. 16, S133-S137 (2010).
30. R. Seggewiss, H. Einsele, Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: An update. Blood 115, 3861-3868 (2010).
31. A. Pallier, S. Hillion, R. Danger, M. Giral, M. Racapé, N. Degauque, E. Dugast, J. Ashton-Chess, S. Pettré, J. J. Lozano, R. Bataille, A.Devys, A. Cesbron-Gautier, C. Braudeau, C. Larrose, J. P. Soulillou, S. Brouard, Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int. 78, 503-513 (2010).
32. E. Rüedi, M. Sykes, S. T. Ildstad, C. H. Chester, A. Althage, H. Hengartner, D. H. Sachs, R. M. Zinkernagel, Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2 → P1) irradiation chimeras. Cell. Immunol. 121, 185-195 (1989).
33. M. M. Martinic, T. Rulicke, A. Althage, B. Odermatt, M. Hochli, A. Lamarre, T. Dumrese, D. E. Speiser, D. Kyburz, H. Hengartner, R. M. Zinkernagel, Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC. Proc. Natl. Acad. Sci. U.S.A. 100, 1861-1866 (2003).
34. + T cell responses develop independent of thymic epithelial MHC. Proc. Natl. Acad. Sci. U.S.A. 103, 14435-14440 (2006).
35. J. Levitsky, Operational tolerance: Past lessons and future prospects. Liver Transpl. 17, 222-232 (2011).
36. E. Akpinar, J. M. Keary, R. Kurlander, D. A. Hale, Measurement of chimerism in cynomolgus monkeys using human-specific short tandem repeat-based assay. Transplantation 79, 236-239 (2005).
37. H. Xu, P. M. Chilton, Y. Huang, C. L. Schanie, S. T. Ildstad, Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J. Immunol. 172, 1463-1471 (2004).
38. F. Baron, J. E. Baker, R. Storb, T. A. Gooley, B. M. Sandmaier, M. B. Maris, D. G.Maloney, S. Heimfeld, D.Oparin, E. Zellmer, J. P. Radich, F. C.Grumet, K. G. Blume, T. R. Chauncey, M. T. Little, Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 104, 2254-2262 (2004).
39. Y. L. Colson, V. R. Shinde Patil, S. T. Ildstad, Facilitating cells: Novel promoters of stem cell alloengraftment and donor-specific transplantation tolerance in the absence of GVHD. Crit. Rev. Oncol. Hematol. 61, 26-43 (2007).
40. S. C. Muluk, M. Clerici, C. S. Via, M. R. Weir, P. L. Kimmel, G. M. Shearer, Correlation of in vitro CD4+ T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients. Transplantation 52, 284-291 (1991).